Express Scripts (ESRX) weekly volatility elevated, into contract with Anthem (ANTM) unlikely to be renewed
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Cowen is a Buyer of Express Scripts (ESRX) on Weakness
April 25, 2017 1:12 PM EDTCowen analyst Charles Rhyee is incrementally positive on Express Scripts (NASDAQ: ESRX) following the earnings call and would be buyers on today's weakness. The analyst reiterated an Outperform rating and price target of $83.
Rhyee sees limited downside risk as ANTM's contribution of... More
Express Scripts (ESRX) PT Lowered to $59 at Evercore ISI
April 25, 2017 12:43 PM EDTEvercore ISI lowered its price target on Express Scripts (NASDAQ: ESRX) to $59.00 (from $68.50) while maintaining a In Line rating.
Analyst Ross Muken commented, "Given the size / scope of the questions outstanding regarding ESRXs business model, we see valuation as... More
Express Scripts (ESRX) PT Lowered to $52 at Morgan Stanley; Renewal Cycle Could Lead to Margin Pressures
April 25, 2017 9:36 AM EDTMorgan Stanley lowered its price target on Express Scripts (NASDAQ: ESRX) to $52.00 (from $71.00) while maintaining a Underweight rating, following news that Anthem intends move its PBM business from the company.
Analyst Ricky Goldwasser lowers estimates on the announcement, suggesting the competitive landscape could deteriorate,... More
